Developing next generation treatments to preserve vision for patients with diseases affecting the back of the eye

Targeting plasma kallikrein with a novel bicyclic peptide inhibitor (THR-149) reduces retinal thickening in a diabetic rat model

Tine Van Bergen. Targeting plasma kallikrein with a novel bicyclic peptide inhibitor (THR-149) reduces retinal thickening in a diabetic rat model 

Publication date: 
November, 2020